INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/30/2025
Back to search
Official data from USPTO
UROGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
12/01/2025
Trademark type
Word
Nice classes
5
Filing date
07/24/2017
Registration date
02/20/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/03/2024
Last transaction
12/01/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
AU
Examiner
MICKLEBURGH,LINDA BOHANNON
Current location
Historical data usage
Holders and representatives
Holders
Divico Pty Ltd
Divico Pty Ltd
Representatives
Nicholas D. Wells Legends Law Group, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietetic beverages adapted for medicinal purposes; dietary supplements; dietetic foods adapted for medical use; food for babies; food supplements for medical purposes; dietetic foods for use in clinical nutrition; nutritional meal replacement powders adapted for medical purposes; nutritional meal replacement bars and drinks adapted for medical purposes; nutritional supplements; nutritional supplement energy bars; nutritional mineral additives for mixing with foods and beverages; mineral food supplements; probiotic bacterial preparations for nutrition supplement; probiotic bacterial formulations for medical use; protein supplements for humans; vitamins
Publications
History of USPTO decisions and trademark events.
36 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/26/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
10/26/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/03/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/03/2024
71AG
REGISTERED-SEC.71 ACCEPTED
10/03/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/03/2024
ES71
TEAS SECTION 71 RECEIVED
02/03/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/07/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/14/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/25/2018
FIMP
FINAL DISPOSITION PROCESSED
05/25/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/20/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
02/20/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/05/2018
GPNX
NOTIFICATION PROCESSED BY IB
12/09/2017
PUBO
PUBLISHED FOR OPPOSITION
12/05/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/22/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/22/2017
NPUB
NOTICE OF PUBLICATION
11/15/2017
UNDN
UNDELIVERABLE MAIL - NO ACTION TAKEN
11/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/20/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2017
ALIE
ASSIGNED TO LIE
10/16/2017
RFNT
REFUSAL PROCESSED BY IB
10/13/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/22/2017
RFRR
REFUSAL PROCESSED BY MPU
09/22/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/20/2017
CNRT
NON-FINAL ACTION WRITTEN
09/19/2017
DOCK
ASSIGNED TO EXAMINER
09/15/2017
MAFR
APPLICATION FILING RECEIPT MAILED
09/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/11/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/07/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/07/2017
Continuous trademark protection
Get notified about every new filing that threatens UROGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.